Logo Image
|Videos|July 14, 2020

Unmet HIV Therapy Needs, Cure Research, and Virtual Conferences

In the second segment of the interview, Gilead’s Gelezinuas and SenGupta discuss the areas of unmet HIV therapy needs, cure research, and the benefits of a virtual conference.

In the first segment of an interview with Contagion®, during the AIDS20202 conference, Gilead’s Romas Gelezinuas, executive director, Biology and Devi SenGupta, MD, senior director, Clinical Research, Virology discuss the HIV investigational therapy, provide some insights in the mechanism of action, as well as what was learned in their study.

Gilead announced results from the study during International AIDS Society (IAS) AIDS 2020 Virtual Sessions.

Here in the second segment of the interview, Gilead’s Gelezinuas and SenGupta discuss the biggest areas of unmet HIV therapy needs, cure research, and the benefits and challenges of the virtual conference experience.

For example, in terms of HIV therapies, Gelezinuas talked about the three areas Gilead is involved in including prevention, treatment, and cure research. One of the areas he is most excited about is long-acting antiretroviral therapies.

To hear the conversation, click on the video below to get more insights.

Related to this article

View more
How The Food Safety Surveillance Infrastructure Works in the US
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Read more
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Read more